Broad Institute CRISPR-Cas9 patent revoked in Europe – Lexology
|
Broad Institute CRISPR-Cas9 patent revoked in Europe
Lexology 17 January 2018 – the Opposition Division (OD) of the European Patent Office (EPO) has today revoked one of the Broad Institute’s foundational CRISPR-Cas9 patents in Europe (EP2771468), upholding the preliminary opinion, which also found all claims of … |
Science Daily |
‘Programmable droplets’ could enable high-volume biology experiments
Science Daily The new approach, which moves solutions around in computationally prescribed patterns, could enable experiments to be conducted more efficiently, cost-effectively, and at larger scales. “Traditional microfluidic systems use tubes, valves, and pumps … |